To hear about similar clinical trials, please enter your email below
Trial Title:
Brazilian Network for Lymphoma Registry
NCT ID:
NCT02265497
Condition:
Lymphoma
Conditions: Official terms:
Lymphoma
Study type:
Observational [Patient Registry]
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
Currently there are no official data concerning incidence, progression and prognosis of
patients with lymphoma in Brazil.This project aims the establishment of a network of 12
Brazilian Institutions to implement a Lymphoma Registry (RELINFO) with the Brazilian
National Cancer Institute (INCA) as the Coordinating Center.We intend to develop and
implement a computerized system for data entry and information management of patients
with lymphomas. This will enable create a virtual registry of demographic, clinical,
epidemiological, histopathological, molecular, and therapeutic data. This clinical record
must be linked to histopathological and molecular diagnosis, allowing institutions that
work in the context of the public health system have access to new technologies for early
cancer diagnosis.We expect is that this record reliably portrays the scene of lymphomas
in our state and will become a management model that can be replicated at the national
level. Thus, the implementation of RELINFO will strengthen the multidisciplinary
diagnosis, promote the standardization of clinical record of patients with lymphomas and
provide subsidies to cooperative research projects between participating institutions.
Detailed description:
Data collection and management:
For data collection will use a common system for all institutions participating.We
developed a computerized tool that utilizes models of case report forms (CRF) and allows
the inclusion and management of clinical, epidemiological, histopathological and
molecular data. The clinical and laboratory data of patients included in RELINFO will be
obtained from the hospital records. The integration of local databases allows constitute
the RELINFO, conceived as a virtual database of patients with lymphoma. The INCA as
Coordinating Center is committed to the security of this database.Standardization of
diagnosisThis phase includes structuring a technological platform for the standardization
of histopathologic diagnosis (establishing common routines in hematopathology) and the
incorporation of molecular methods in the diagnosis of lymphoma.
Criteria for eligibility:
Study pop:
All patients with diagnosis of Hodgkin's or non-Hodgkin lymphoma with available with
available clinical, histopathology and treatment data.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- All patients (adult or child) with diagnosis of Hodgkin's or non-Hodgkin lymphoma
with available with available clinical, histopathology and treatment data
- Patient enrolled on study sites included on this project
Exclusion Criteria:
- Patients (adult or child) with other diagnoses of cancer
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Brazilian National Cancer Institute - INCA/ Ministry Of HealthClinical Research Department
Address:
City:
Rio de Janeiro
Zip:
20231-050
Country:
Brazil
Status:
Recruiting
Contact:
Last name:
Claudio Gustavo Stefanoof, Doctor
Phone:
+55 21 32076541
Contact backup:
Last name:
Adriana A Scheliga, Master
Phone:
+55 21 32076585
Investigator:
Last name:
Adilson José Almeida
Email:
Principal Investigator
Investigator:
Last name:
Monica Praxedes
Email:
Principal Investigator
Investigator:
Last name:
Fernando M Pinto
Email:
Principal Investigator
Investigator:
Last name:
Rita Elizabete G Espariz
Email:
Principal Investigator
Investigator:
Last name:
Luciana Conti
Email:
Principal Investigator
Investigator:
Last name:
Glaucia Guasti
Email:
Principal Investigator
Investigator:
Last name:
Juliana G Musacchio
Email:
Principal Investigator
Investigator:
Last name:
Leonardo G Leite
Email:
Principal Investigator
Start date:
March 2014
Completion date:
December 2025
Lead sponsor:
Agency:
Claudio Gustavo Stefanoff
Agency class:
Other
Collaborator:
Agency:
Adriana Alves de Souza Scheliga
Agency class:
Other
Collaborator:
Agency:
Claudete Esteves Nogueira Pinto Klumb
Agency class:
Other
Collaborator:
Agency:
Ricardo de Sá Bigni
Agency class:
Other
Collaborator:
Agency:
Luciana Wernersbach Pinto
Agency class:
Other
Collaborator:
Agency:
Rocio Hassan
Agency class:
Other
Collaborator:
Agency:
Isabele Avila Small
Agency class:
Other
Collaborator:
Agency:
Monik Mariano Pinto
Agency class:
Other
Collaborator:
Agency:
Cecilia Ferreira da Silva
Agency class:
Other
Source:
Instituto Nacional de Cancer, Brazil
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT02265497
